The present disclosure relates generally to compounds having activity as voltage-gated sodium channel blockers and their use in the field of therapeutic treatment, including the therapy or management of conditions associated with excessive, unwanted, inadequate or otherwise undesirable sodium ion passage through cellular membranes via voltage-gated sodium channels. In some embodiments, the disclosure relates to aryloxy-substituted amines for use as sodium channel blockers or modulators. Methods for their manufacture and compositions containing the compounds are also disclosed.
本公开涉及一般具有作为电压门控
钠通道阻滞剂活性的化合物以及它们在治疗领域中的使用,包括治疗或管理与通过细胞膜的电压门控
钠通道传递过多、不需要、不足或其他不良的
钠离子通道相关的疾病。在某些实施例中,本公开涉及用作
钠通道阻滞剂或调节剂的芳基氧代胺。还公开了它们的制造方法和含有这些化合物的组合物。